IE33603B1 - Vaccines - Google Patents

Vaccines

Info

Publication number
IE33603B1
IE33603B1 IE143069A IE143069A IE33603B1 IE 33603 B1 IE33603 B1 IE 33603B1 IE 143069 A IE143069 A IE 143069A IE 143069 A IE143069 A IE 143069A IE 33603 B1 IE33603 B1 IE 33603B1
Authority
IE
Ireland
Prior art keywords
allergenic material
haloformate
oct
chloroformate
allergenic
Prior art date
Application number
IE143069A
Other versions
IE33603L (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE33603L publication Critical patent/IE33603L/en
Publication of IE33603B1 publication Critical patent/IE33603B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1,243,832. Allergens. BEECHAM GROUP Ltd. 23 Oct., 1969 [25 Oct., 1968], No. 50645/ 68. Heading A5B. The allergenicity of an allergenic material is reduced by treating the allergenic material with a haloformate having the formula RO.CO.X wherein X is a halogen and R is alkyl, alkenyl, aryl, aralkyl, arylcarbonyl or a heterocyclic group, at a pH of from 1 to 7 and recovering the resultant modified allergenic material. The haloformate is preferably a chloroformate especially methyl, ethyl or benzoyl chloroformate. The temperature employed for the treatment is preferably about 20‹C. The allergenic material treated may be a protein or glycoprotein extract of the whole allergen. The allergenic material may be, or may be derived from, pollen. Pharmaceutical preparations for parenteral administration comprise the modified allergenic material and a parenterally acceptable carrier. [GB1243832A]
IE143069A 1968-10-25 1969-10-20 Vaccines IE33603B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5064568A GB1243832A (en) 1968-10-25 1968-10-25 Vaccines

Publications (2)

Publication Number Publication Date
IE33603L IE33603L (en) 1970-04-25
IE33603B1 true IE33603B1 (en) 1974-08-21

Family

ID=10456759

Family Applications (1)

Application Number Title Priority Date Filing Date
IE143069A IE33603B1 (en) 1968-10-25 1969-10-20 Vaccines

Country Status (10)

Country Link
AT (1) AT293617B (en)
BE (1) BE740801A (en)
CH (1) CH536633A (en)
DE (1) DE1953995A1 (en)
DK (1) DK125308B (en)
ES (1) ES372843A1 (en)
FR (1) FR2021556B1 (en)
GB (1) GB1243832A (en)
IE (1) IE33603B1 (en)
NL (1) NL6916121A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2178582B1 (en) * 2000-12-01 2003-11-01 Lozano Juan Jose Martin CUP PROFILE, FOR THE ASSEMBLY OF TWO FLOORS OF ELECTRIC PANELS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174854A (en) * 1967-07-07 1969-12-17 Miles Lab New Biologically Active Conjugates

Also Published As

Publication number Publication date
GB1243832A (en) 1971-08-25
NL6916121A (en) 1970-04-28
FR2021556A1 (en) 1970-07-24
AT293617B (en) 1971-10-25
BE740801A (en) 1970-04-24
DE1953995A1 (en) 1970-04-30
CH536633A (en) 1973-05-15
FR2021556B1 (en) 1973-01-12
IE33603L (en) 1970-04-25
ES372843A1 (en) 1971-11-01
DK125308B (en) 1973-02-05

Similar Documents

Publication Publication Date Title
NL7800767A (en) ADDITIONAL CONNECTION OF DIPEPTIDE DERIVATIVE AND AMINO ACID DERIVATIVE AS WELL AS THE PROCEDURE FOR PREPARING THIS.
NL181628C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH PROSTAGLANDINE-LIKE ACTION, AND METHOD FOR PREPARING 9-ALFA, 11-ALFA, 15-ALFA-TRIHYDROXY-PROSTA-4,5,13-TRI-ACID DERIVATIVES, PREVIOUSLY USED
EP0726758A4 (en) Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
IE35642B1 (en) A process for the preparation of new alpha-aminopenicillins and such penicillins and intermediates and pharmaceutical preparations
NL7607649A (en) PROCESS FOR PREPARING N- (3-TRIFLUORM-THYL 4-HALOGENOPHENYL) N'-BENZOYLUREA, AND PROCESS FOR PREPARING INSECTICIDE PREPARATIONS ON THE BASIS AND THEIR USE OF THEIR INJECTORS.
EP0342860A3 (en) Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
ATE99953T1 (en) COMBINATION ANTIVIRAL MEDICATION.
NZ221379A (en) Nematode plasma membrane-associated protein, extraction method and vaccines containing it
DE3751772D1 (en) Vaccine for the treatment of HSV
IE33603B1 (en) Vaccines
NL7803030A (en) NEW ESTERS OF AMINO ACIDS AND NEW INTERMEDIATE PRODUCTS THEREOF, AND PROCEDURES FOR PREPARING AND USING THESE COMPOUNDS.
NL169337C (en) PROCESS FOR THE PREPARATION OF FORMULAS OF MACROMOLECULAR THERMOPLASTIC POLYCARBONATES, AND PREPARED PREPARATIONS THEREOF.
EP0299050A4 (en) Isolation of single chain proteins with fsh suppressing activity from follicular fluid.
Itil Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
GB1114683A (en) Process for purifying proteinaceous fractions from mistletoe by ultracentrifugation
IE32044L (en) Tetanus vaccine
NL7609794A (en) TRIFLUORMETHYL CONTAINING ARALKYL ESTERS OF AMINO ACIDS, PHARMACEUTICAL PREPARATION AND METHODS FOR PREPARING THEM
DE3781049D1 (en) METHOD FOR PRODUCING HEPATITIS B VIRUS INTERNAL BODY IMPERANTIGENS (HBCAG) IN YEAST.
NL8001205A (en) SPECTINOMYCIN ANALOGA, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL PREPARATIONS PREPARED THEREFROM.
NL7510068A (en) PROCEDURE FOR PREPARING ESTERS OF 5-N-BUTYL-PYRIDINECARBONIC ACID- (2), PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SUCH AS FORMED.
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB1108245A (en) A diuretic antitoxic and mental-stimulating extract of mammalian brain and a process for its production